Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Cerebrovascular Diseases (Basel, Switzerland)|February 12, 1999
Transient muteness followed by dysarthria in patients with pontomesencephalic stroke. Report of two casesG Orefice, N A Fragassi, R Lanzillo, et al.Acta Neurologica Scandinavica|July 1, 2016
Predictors of the 10-year direct costs for treating multiple sclerosisM Moccia, R Palladino, R Lanzillo, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 18, 2002
Aphasia as a rare presentation of monosymptomatic demyelinating disease: case report and review of the literatureL Di Majo, M Bisceglia, R Lanzillo, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2015
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosisE Signoriello, R Lanzillo, V Brescia Morra, et al.Annals of Human Genetics|April 23, 2005
Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severityA Carsana, G Frisso, M R Tremolaterra, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Multiple sclerosis and headache co-morbidity. A case-control studyG Vacca, E Marano, V Brescia Morra, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2004
Epileptic seizures in multiple sclerosis: clinical and EEG correlationsP Striano, G Orefice, V Brescia Morra, et al.Acta Neurologica Scandinavica|December 16, 2016
A longitudinal real-life comparison study of natalizumab and fingolimodR Lanzillo, A Carotenuto, M Moccia, et al.Developmental Medicine and Child Neurology|March 18, 2006
Early onset calpainopathy with normal non-functional calpain 3 levelR Lanzillo, S Aurino, M Fanin, et al.Journal of Neurology|May 23, 2006
A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathyL Santoro, F Manganelli, R Lanzillo, et al.Pageof 5